Targeted Therapy for Biliary Tract Cancer

by Furuse, Junji, Okusaka, Takuji
Published 2011

Past exposure to hepatitis B virus as a risk factor for hepatocellular carcinoma in patients with chronic liver disease.

by Okada, S., Sato, T., Okusaka, T., Ishii, H., Ikeda, M., Nakasuka, H., Kosakamoto, H., Yoshimori, M., Wakabayashi, K.
Published 1998

Circulating endothelial cells and other angiogenesis factors in pancreatic carcinoma patients receiving gemcitabine chemotherapy

by Kondo, Shunsuke, Ueno, Hideki, Hashimoto, Jun, Morizane, Chigusa, Koizumi, Fumiaki, Okusaka, Takuji, Tamura, Kenji
Published 2012

Clinical impact of pentraxin family expression on prognosis of pancreatic carcinoma

by Kondo, S, Ueno, H, Hosoi, H, Hashimoto, J, Morizane, C, Koizumi, F, Tamura, K, Okusaka, T
Published 2013

Hepatitis B Virus Reactivation during Treatment with Multi-Tyrosine Kinase Inhibitor for Hepatocellular Carcinoma

by Shiba, Satoshi, Kondo, Shunsuke, Ueno, Hideki, Morizane, Chigusa, Ikeda, Masafumi, Okusaka, Takuji
Published 2012

A retrospective analysis of factors associated with selection of end-of-life care and actual place of death for patients with cancer

by Kondo, Shunsuke, Shimazu, Taichi, Morizane, Chigusa, Hosoi, Hiroko, Okusaka, Takuji, Ueno, Hideki
Published 2014

Phase II study of FOLFIRINOX for chemotherapy-naïve Japanese patients with metastatic pancreatic cancer

by Okusaka, Takuji, Ikeda, Masafumi, Fukutomi, Akira, Ioka, Tatsuya, Furuse, Junji, Ohkawa, Shinichi, Isayama, Hiroyuki, Boku, Narikazu
Published 2014

Response to Y. Sasaki et al.: Is repeating FOLFIRINOX in the original dosage and treatment schedule tolerable in Japanese patients with pancreatic cancer?

by Okusaka, Takuji, Ikeda, Masafumi, Fukutomi, Akira, Ioka, Tatsuya, Furuse, Junji, Ohkawa, Shinichi, Isayama, Hiroyuki, Boku, Narikazu
Published 2015

Interaction of natural killer cells with neutrophils exerts a significant antitumor immunity in hematopoietic stem cell transplantation recipients

by Ueda, Ryosuke, Narumi, Kenta, Hashimoto, Hisayoshi, Miyakawa, Reina, Okusaka, Takuji, Aoki, Kazunori
Published 2015

Salvage chemoradiotherapy after primary chemotherapy for locally advanced pancreatic cancer: a single-institution retrospective analysis

by Mayahara, Hiroshi, Ito, Yoshinori, Morizane, Chigusa, Ueno, Hideki, Okusaka, Takuji, Kondo, Shunsuke, Murakami, Naoya, Morota, Madoka, Sumi, Minako, Itami, Jun
Published 2012

A multicenter phase II study of S-1 for gemcitabine-refractory biliary tract cancer

by Suzuki, Eiichiro, Ikeda, Masafumi, Okusaka, Takuji, Nakamori, Shoji, Ohkawa, Shinichi, Nagakawa, Tatsuya, Boku, Narikazu, Yanagimoto, Hiroaki, Sato, Tosiya, Furuse, Junji
Published 2013

Everolimus for Advanced Pancreatic Neuroendocrine Tumours: A Subgroup Analysis Evaluating Japanese Patients in the RADIANT-3 Trial

by Ito, Tetsuhide, Okusaka, Takuji, Ikeda, Masafumi, Igarashi, Hisato, Morizane, Chigusa, Nakachi, Kohei, Tajima, Takeshi, Kasuga, Akio, Fujita, Yoshie, Furuse, Junji
Published 2012

Regorafenib in Japanese patients with solid tumors: phase I study of safety, efficacy, and pharmacokinetics

by Sunakawa, Yu, Furuse, Junji, Okusaka, Takuji, Ikeda, Masafumi, Nagashima, Fumio, Ueno, Hideki, Mitsunaga, Shuichi, Hashizume, Kensei, Ito, Yuichiro, Sasaki, Yasutsuna
Published 2013

Transarterial infusion chemotherapy with cisplatin plus S-1 for hepatocellular carcinoma treatment: a phase I trial

by Terazawa, Tetsuji, Kondo, Shunsuke, Hosoi, Hiroko, Morizane, Chigusa, Shimizu, Satoshi, Mitsunaga, Shuichi, Ikeda, Masafumi, Ueno, Hideki, Okusaka, Takuji
Published 2014

Erratum to: Regorafenib in Japanese patients with solid tumors: phase I study of safety, efficacy, and pharmacokinetics

by Sunakawa, Yu, Furuse, Junji, Okusaka, Takuji, Ikeda, Masafumi, Nagashima, Fumio, Ueno, Hideki, Mitsunaga, Shuichi, Hashizume, Kensei, Ito, Yuichiro, Sasaki, Yasutsuna
Published 2013

Antibody-based proteomics to identify an apoptosis signature for early recurrence of hepatocellular carcinoma

by Morofuji, Noriaki, Ojima, Hidenori, Hiraoka, Nobuyoshi, Okusaka, Takuji, Esaki, Minoru, Nara, Satoshi, Shimada, Kazuaki, Kishi, Yoshiro, Kondo, Tadashi
Published 2016

Phase I study of tivantinib in Japanese patients with advanced hepatocellular carcinoma: Distinctive pharmacokinetic profiles from other solid tumors

by Okusaka, Takuji, Aramaki, Takeshi, Inaba, Yoshitaka, Nakamura, Shinichiro, Morimoto, Manabu, Moriguchi, Michihisa, Sato, Takashi, Ikawa, Yuta, Ikeda, Masafumi, Furuse, Junji
Published 2015

Japanese phase I study of GC33, a humanized antibody against glypican-3 for advanced hepatocellular carcinoma

by Ikeda, Masafumi, Ohkawa, Shinichi, Okusaka, Takuji, Mitsunaga, Shuichi, Kobayashi, Satoshi, Morizane, Chigusa, Suzuki, Ikue, Yamamoto, Shunsuke, Furuse, Junji
Published 2014

Early Relapse of Unresectable Gallbladder Cancer after Discontinuation of Gemcitabine Monotherapy Administered for 5 Years in a Patient Who Had Complete Response to the Treatment

by Suyama, Koichi, Ikeda, Masafumi, Suzuki, Eiichiro, Kojima, Motohiro, Mitsunaga, Shuichi, Shimizu, Satoshi, Ohno, Izumi, Takahashi, Hideaki, Okuyama, Hiroyuki, Kuwahara, Akiko, Okusaka, Takuji, Furuse, Junji
Published 2013

Association of Pancreatic Fatty Infiltration With Pancreatic Ductal Adenocarcinoma

by Hori, Mika, Takahashi, Mami, Hiraoka, Nobuyoshi, Yamaji, Taiki, Mutoh, Michihiro, Ishigamori, Rikako, Furuta, Koh, Okusaka, Takuji, Shimada, Kazuaki, Kosuge, Tomoo, Kanai, Yae, Nakagama, Hitoshi
Published 2014